Skip to main content
. Author manuscript; available in PMC: 2019 Sep 5.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2018 Apr 14;27(6):660–667. doi: 10.1002/pds.4437

TABLE 2.

Percent positive agreement between datasetsa

Full Dataset Percent Positive Agreement, %
SDR No SDR
Cardiovascular Subset SDR Acute myocardial infarction 1 0 100.0
Atrioventricular block complete 2 0 66.7
Cardiogenic shock 2 1 66.7
Myocardial infarction 5 1 71.4
Arteriosclerosis coronary artery 0 1 0.0
Cardiac arrest 1 1 50.0
Cardiac failure 1 2 33.3
Cardiac failure congestive 2 0 33.3
Sudden death 0 3 0.0
Sudden cardiac death 1 1 50.0
Cerebrovascular accident 0 1 0.0
Cerebral infarction 1 0 50.0
Hemorrhagic stroke 1 0 100.0
Ischemic stroke 1 1 33.3
No SDR Acute myocardial infarction 0 20
Atrioventricular block complete 1 18
Cardiogenic shock 0 18
Myocardial infarction 1 14
Arteriosclerosis coronary artery 1 19
Cardiac arrest 0 19
Cardiac failure 0 18
Cardiac failure congestive 4 15
Sudden death 0 18
Sudden cardiac death 0 19
Cerebrovascular accident 3 17
Cerebral infarction 1 19
Hemorrhagic stroke 0 20
Ischemic stroke 1 18

Abbreviation: SDR, signal of disproportional reporting.

a

There were 21 total drug event combinations involving DPP-4i, sulfonylureas, and biguanides with major adverse cardiac events.